CO-1686

The Battle For Lung Cancer Drugs Continues
Bidness Etc.
Tue, 10/7/14 - 01:45 pm
lung cancer
AstraZeneca
Clovis Oncology
AZD9291
CO-1686
This Week in Biotech: A Trifecta of Disappointment Mars ASCO While Biogen Scores a Big Victory
Motley Fool
Mon, 06/9/14 - 09:17 am
ASCO
Biogen Idec
Elocate
neratinib
Puma Biotechnology
CO-1686
Clovis Oncology
Tykerb
GSK
Roche
[video]Clovis CEO: We can win against AstraZeneca
CNBC
Tue, 06/3/14 - 02:23 pm
AstraZeneca
Clovis Oncology
ASCO
CO-1686
lung cancer
AZD9291
Tuesday’s Top Biotech Stories: Vanda Pharmaceuticals, Prosensa, and Clovis Oncology
Motley Fool
Tue, 06/3/14 - 11:38 am
Vanda
Prosensa
Clovis Oncology
Hetlioz
CO-1686
drisapersen
Clovis' Lung Cancer Bravado Falls Flat With New Diabetes Revelation
TheStreet.com
Mon, 06/2/14 - 09:44 am
Clovis Oncology
diabetes
CO-1686
AZD9291
lung cancer
ASCO
Clovis shares jump as company prepares to give cancer drug results
Marketwatch
Thu, 05/15/14 - 06:08 pm
Clovis Oncology
CO-1686
Losses widen, but investors heartened by Clovis drug results
Markewatch
Fri, 02/28/14 - 11:42 am
Clovis Oncology
earnings
CO-1686
3 Biotechs Generating a Lot Of Buzz
Wall St Cheat Sheet
Mon, 01/13/14 - 02:47 pm
Celgene
Arrowhead Research
Clovis Oncology
ARC-520
CO-1686
Lucitanib
rucaparib
Opportunities in Lung Cancer Therapies
Motley Fool
Sun, 11/24/13 - 12:30 pm
lung cancer
non-small cell lung cancer
Avastin
Genentech
Roche
Tarceva
AstraZeneca
Iressa
Alimta
selumetinib
Array Biopharma
CO-1686
Clovis Oncology
AP26113
Ariad Pharmaceuticals
Clovis, Synta, and Incyte Could Be Big Movers Today
Motley Fool
Tue, 10/29/13 - 09:42 am
Clovis Oncology
Synta
Incyte
CO-1686
non-small cell lung cancer
ganetespib
INCB39110
rheumatoid arthritis
With Promising Results, AstraZeneca Targets Mutated Lung Cancer And Rival Clovis Drug
TheStreet.com
Mon, 09/30/13 - 10:31 am
AZD9291
Clovis Oncology
AstraZeneca
CO-1686
non-small cell lung cancer
5 Experimental Drugs That Could Make a Big Difference in Treating Lung Cancer
Motley Fool
Sun, 09/22/13 - 11:23 am
LDK378
Novartis
bavituximab
Peregrine Pharmaceuticals
nivolumab
Bristol-Myers Squibb
lambrolizumab
Merck
lung cancer
CO-1686
Clovis Oncology
Clovis / CO-1686: Value, Derived From Data, Supports The Valuation
Seeking Alpha
Wed, 06/12/13 - 09:07 am
CO-1686
Clovis Oncology
non-small cell lung cancer
Clovis Oncology Skyrockets After ASCO Presentations
Seeking Alpha
Tue, 06/4/13 - 12:28 pm
ASCO
Clovis Oncology
CO-1686
rucaparib